Clinical Trials
675
Active:13
Completed:196
Trial Phases
6 Phases
Early Phase 1:5
Phase 1:13
Phase 2:21
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (295 trials with phase data)• Click on a phase to view related trials
Not Applicable
211 (71.5%)Phase 4
37 (12.5%)Phase 2
21 (7.1%)Phase 1
13 (4.4%)Phase 3
8 (2.7%)Early Phase 1
5 (1.7%)Effect of Foot Core Control Training on Dorsiflexion Function and Gait Biomechanical Characteristics of Patients With Chronic Plantar Fasciitis
Not Applicable
Not yet recruiting
- Conditions
- Chronic Plantar FasciitisFunctional Hallux Limitus
- First Posted Date
- 2025-09-19
- Last Posted Date
- 2025-09-19
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 34
- Registration Number
- NCT07182201
TNF-α Antagonists Mitigate Systemic Inflammatory Response After Cardiac Arrest.
Not Applicable
Not yet recruiting
- Conditions
- Cardiac Arrest (CA)Post Cardiac Arrest Syndrome
- Interventions
- Drug: Sodium chloride injection USP, 0.9% (placebo)
- First Posted Date
- 2025-09-16
- Last Posted Date
- 2025-09-16
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 208
- Registration Number
- NCT07176754
Safety and Effectiveness of No-touch Technique for Ascending Aorta in MICS-CABG
Recruiting
- Conditions
- Coronary Artery Bypass GraftingOff-pump Coronary Artery BypassMinimally Invasive Cardiac SurgeryCoronary Arterial Disease (CAD)
- First Posted Date
- 2025-09-15
- Last Posted Date
- 2025-09-15
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 260
- Registration Number
- NCT07172620
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing Municipality, China
A Real-world Study on the Influencing Factors of Efficacy of Ruxolitinib Cream in Vitiligo
- First Posted Date
- 2025-09-04
- Last Posted Date
- 2025-09-04
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 170
- Registration Number
- NCT07153666
Value of Super-resolution Ultrasonography in Differentiating Benign and Malignant Lymph Nodes
Recruiting
- Conditions
- LymphadenopathyLymphnode MetastasisLymphomaLymphatic Tuberculosis
- First Posted Date
- 2025-09-04
- Last Posted Date
- 2025-09-04
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 779
- Registration Number
- NCT07155954
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing Municipality, China
- Prev
- 1
- 2
- 3
- 4
- 5
- 134
- Next
News
No news found